Jin Qinglin, Xie Xianbiao, Yao Hao, Wen Lili, Li Hongbo, Lv Dongming, Zeng Ziliang, Wang Yongqian, Zou Changye, Yin Junqiang, Huang Gang, Wang Bo, Shen Jingnan
Department of Musculoskeletal Oncology Center, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan 2 nd Rd, Guangzhou 510080, China.
Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, Guangzhou 510080, China.
J Cancer. 2020 Mar 5;11(11):3235-3245. doi: 10.7150/jca.42341. eCollection 2020.
: Osteosarcoma is one of the most prevalent primary bone malignancies in children and adolescents. Magnetic resonance imaging (MRI) has been considered a very critical tool to provide anatomical information of tumor and surrounding main blood vessels. To evaluate the prognostic significance of the radiological vascular involvement according to the pre-treatment MRI in patients with Enneking IIB osteosarcoma. : In this retrospective study, we included 482 patients younger than 50 years old with Enneking IIB primary osteosarcoma of the extremities with complete clinical records from 2005 to 2015.Univariate and multivariable analyses were conducted to identify the risk factors for OS (Overall survival) and EFS (Event-free survival). The correlations between the risk factors was performed using Spearman analysis. The Kaplan-Meier method was used to calculate survival curves. Based on the radiological relationship between the tumor lesion and the surrounding reactive area with the main blood vessels as shown on pretreatment MRI findings. : Radiological vascular involvement assessed via pretreatment MRI is an important risk factor for Enneking IIB primary patients with osteosarcoma (HR=2.32/HR=1.81 P<0.01) according to the univariate and multivariable analyses. Enneking IIB patients with osteosarcoma were assigned to three subtypes based on the radiological relationship between the main blood vessels and the lesion or reactive area. The 5-year cumulative OS of patients classified by the three types were 81.6% (type I), 67.1% (type II) and 44.8% (type III)(P<0.01). The 5-year cumulative EFS of the three types were 60.2% (type I), 46.7% (type II) and 30.2% (type III)(P<0.05). The total 5-year cumulative OS and EFS for all patients were 68.3% and 48.3%, respectively. : Vascular involvement according to radiological findings from pretreatment MRI is an independent risk factor for cumulative OS and EFS in patients with Enneking IIB primary osteosarcoma of the extremities. The new subtyping based on the relationship between the tumors and surrounding reactive area with the main blood vessels based on pretreatment MRI can predict the prognosis of patients with osteosarcoma and provide certain directive information for selecting the appropriate surgical procedure for individual patients.
骨肉瘤是儿童和青少年中最常见的原发性骨恶性肿瘤之一。磁共振成像(MRI)被认为是提供肿瘤及周围主要血管解剖信息的关键工具。旨在根据治疗前MRI评估Enneking IIB期骨肉瘤患者放射学血管受累情况的预后意义。
在这项回顾性研究中,我们纳入了482例年龄小于50岁、2005年至2015年患有Enneking IIB期肢体原发性骨肉瘤且临床记录完整的患者。进行单因素和多因素分析以确定总生存期(OS)和无事件生存期(EFS)的危险因素。使用Spearman分析来评估危险因素之间的相关性。采用Kaplan-Meier法计算生存曲线。根据治疗前MRI表现中肿瘤病变与周围反应区及主要血管之间的放射学关系进行分析。
根据单因素和多因素分析,通过治疗前MRI评估的放射学血管受累是Enneking IIB期原发性骨肉瘤患者的重要危险因素(HR=2.32/HR=1.81,P<0.01)。根据主要血管与病变或反应区之间的放射学关系,将Enneking IIB期骨肉瘤患者分为三个亚型。三种类型患者的5年累积总生存率分别为81.6%(I型)、67.1%(II型)和44.8%(III型)(P<0.01)。三种类型的5年累积无事件生存率分别为60.2%(I型)、46.7%(II型)和30.2%(III型)(P<0.05)。所有患者的5年累积总生存率和无事件生存率分别为68.3%和48.3%。
根据治疗前MRI的放射学表现评估的血管受累是Enneking IIB期肢体原发性骨肉瘤患者累积总生存期和无事件生存期的独立危险因素。基于治疗前MRI中肿瘤与周围反应区及主要血管之间关系的新亚型分类可预测骨肉瘤患者的预后,并为个体患者选择合适的手术方式提供一定的指导信息。